RUNX3

UniProt ID: Q13761
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

RUNX3 encodes Runt-related transcription factor 3, a nuclear Runt-domain DNA-binding transcription factor that heterodimerizes with CBFβ/core-binding factor complexes to regulate RNA polymerase II target-gene programs. Its core function is sequence-specific regulatory DNA and chromatin binding for context-dependent transcriptional activation or repression, with important downstream roles in development, TGF-beta/Wnt/Hippo signaling, CD8 T-cell biology, and cancer-associated mislocalization or degradation.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
IBA
GO_REF:0000033
ACCEPT
Summary: RNA polymerase II cis-regulatory region sequence-specific DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
GO:0001503 ossification
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: ossification is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0030097 hemopoiesis
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: hemopoiesis is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0030182 neuron differentiation
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: neuron differentiation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0045595 regulation of cell differentiation
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: regulation of cell differentiation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0006357 regulation of transcription by RNA polymerase II
IBA
GO_REF:0000033
ACCEPT
Summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
Reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription factor.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
IBA
GO_REF:0000033
ACCEPT
Summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the best-supported core molecular function of RUNX3.
Reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0002062 chondrocyte differentiation
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: chondrocyte differentiation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0003677 DNA binding
IEA
GO_REF:0000120
MODIFY
Summary: Generic DNA binding is directionally correct but less precise than RUNX3 sequence-specific regulatory DNA binding.
Reason: RUNX3 is not merely a generic DNA-binding protein; its supported molecular role is sequence-specific Runt-domain binding at regulatory regions.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
GO:0003700 DNA-binding transcription factor activity
IEA
GO_REF:0000002
MODIFY
Summary: Generic DNA-binding transcription factor activity is correct but less precise than the RNA polymerase II-specific term already present.
Reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the more specific term is preferred.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0005524 ATP binding
IEA
GO_REF:0000002
REMOVE
Summary: ATP binding is not supported as a RUNX3 molecular function.
Reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
GO:0005634 nucleus
IEA
GO_REF:0000120
ACCEPT
Summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005737 cytoplasm
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: cytoplasm localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0006355 regulation of DNA-templated transcription
IEA
GO_REF:0000002
MODIFY
Summary: Generic regulation of DNA-templated transcription is supported but should be captured with the RNA polymerase II-specific process.
Reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA polymerase II.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0045893 positive regulation of DNA-templated transcription
IEA
GO_REF:0000117
ACCEPT
Summary: Positive regulation of DNA-templated transcription is supported in context-specific RUNX3 target-gene programs.
Reason: RUNX3 can activate transcriptional targets, although the direction of regulation is context dependent.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 study (Cancer Research Communications) presented evidence that RUNX3 can be **pro-metastatic** in a gastric cancer model (HGC-27), where CRISPR KO reduced migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo. Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of metastasis-associated targets including **WNT5A**, **CD44**, and **VIM**, with WNT5A functioning as a major effector.
GO:1990837 sequence-specific double-stranded DNA binding
IEA
GO_REF:0000117
ACCEPT
Summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
GO:0005515 protein binding
IPI
PMID:18772112
RUNX3 attenuates beta-catenin/T cell factors in intestinal t...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0005515 protein binding
IPI
PMID:24229708
Runx3 inactivation is a crucial early event in the developme...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0005515 protein binding
IPI
PMID:38424632
Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0005515 protein binding
IPI
PMID:9751710
Transcriptional repression by AML1 and LEF-1 is mediated by ...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005829 cytosol
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0006357 regulation of transcription by RNA polymerase II
IDA
PMID:20591170
The Runx transcriptional co-activator, CBFbeta, is essential...
ACCEPT
Summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
Reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription factor.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0001222 transcription corepressor binding
IPI
PMID:9751710
Transcriptional repression by AML1 and LEF-1 is mediated by ...
ACCEPT
Summary: Transcription corepressor binding is supported by RUNX/Runt-domain recruitment of TLE/Groucho corepressors.
Reason: This is a more informative binding annotation than generic protein binding for RUNX3-associated transcriptional repression.
Supporting Evidence:
PMID:9751710
The mammalian AML/CBFalpha runt domain (RD) transcription factors regulate hematopoiesis and osteoblast differentiation. Like their Drosophila counterparts, most mammalian RD proteins terminate in a common pentapeptide, VWRPY, which serves to recruit the corepressor Groucho (Gro).
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
GO:1990837 sequence-specific double-stranded DNA binding
IDA
PMID:28473536
Impact of cytosine methylation on DNA binding specificities ...
ACCEPT
Summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
GO:0000785 chromatin
ISA
GO_REF:0000113
ACCEPT
Summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and chromatin-remodeler-associated activity.
Reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 associates with **CBFβ** and chromatin remodeler machinery including SWI/SNF components; the **Runt domain** is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
ISA
GO_REF:0000113
ACCEPT
Summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the best-supported core molecular function of RUNX3.
Reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0016513 core-binding factor complex
TAS
PMID:18258917
Repression of the transcription factor Th-POK by Runx comple...
ACCEPT
Summary: Core-binding factor complex is the canonical RUNX3 transcription factor complex context.
Reason: RUNX3 heterodimerizes with CBFβ, placing it in the core-binding factor complex for DNA-binding transcriptional regulation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 associates with **CBFβ** and chromatin remodeler machinery including SWI/SNF components; the **Runt domain** is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model.
GO:0043371 negative regulation of CD4-positive, alpha-beta T cell differentiation
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: negative regulation of CD4-positive, alpha-beta T cell differentiation is a supported RUNX3 biological role, especially in immune differentiation, but it is downstream of the transcription factor core function.
Reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs rather than a separate core molecular activity.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is a key regulator of **CD8+ T-cell differentiation, infiltration, effector/memory fate, and residency**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
GO:0043378 positive regulation of CD8-positive, alpha-beta T cell differentiation
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: positive regulation of CD8-positive, alpha-beta T cell differentiation is a supported RUNX3 biological role, especially in immune differentiation, but it is downstream of the transcription factor core function.
Reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs rather than a separate core molecular activity.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is a key regulator of **CD8+ T-cell differentiation, infiltration, effector/memory fate, and residency**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952419
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005829 cytosol
TAS
Reactome:R-HSA-8952399
KEEP AS NON CORE
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8952408
KEEP AS NON CORE
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952382
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952399
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8951966
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8951977
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952058
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952062
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952069
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005829 cytosol
TAS
Reactome:R-HSA-8937792
KEEP AS NON CORE
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8937807
KEEP AS NON CORE
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0005829 cytosol
TAS
Reactome:R-HSA-8937814
KEEP AS NON CORE
Summary: cytosol localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8865454
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8878117
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8878143
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8878178
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8878193
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8878220
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8878237
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8937814
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8949335
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8951428
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8951676
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8951910
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8951951
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952128
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952226
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-8952371
ACCEPT
Summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005515 protein binding
IPI
PMID:20599712
Tumor suppressor, AT motif binding factor 1 (ATBF1), translo...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0005634 nucleus
IDA
PMID:20599712
Tumor suppressor, AT motif binding factor 1 (ATBF1), translo...
ACCEPT
Summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0005737 cytoplasm
IDA
PMID:20599712
Tumor suppressor, AT motif binding factor 1 (ATBF1), translo...
KEEP AS NON CORE
Summary: cytoplasm localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0045893 positive regulation of DNA-templated transcription
IDA
PMID:20599712
Tumor suppressor, AT motif binding factor 1 (ATBF1), translo...
ACCEPT
Summary: Positive regulation of DNA-templated transcription is supported in context-specific RUNX3 target-gene programs.
Reason: RUNX3 can activate transcriptional targets, although the direction of regulation is context dependent.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 study (Cancer Research Communications) presented evidence that RUNX3 can be **pro-metastatic** in a gastric cancer model (HGC-27), where CRISPR KO reduced migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo. Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of metastasis-associated targets including **WNT5A**, **CD44**, and **VIM**, with WNT5A functioning as a major effector.
GO:0071559 response to transforming growth factor beta
IDA
PMID:20599712
Tumor suppressor, AT motif binding factor 1 (ATBF1), translo...
KEEP AS NON CORE
Summary: Response to transforming growth factor beta is supported as a pathway context for RUNX3 transcriptional regulation.
Reason: TGF-beta/SMAD effects are important context-specific biology, but the core function remains nuclear sequence-specific transcriptional regulation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
GO:0005515 protein binding
IPI
PMID:17377532
Foxp3 controls regulatory T-cell function by interacting wit...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0000785 chromatin
ISS
GO_REF:0000024
ACCEPT
Summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and chromatin-remodeler-associated activity.
Reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 associates with **CBFβ** and chromatin remodeler machinery including SWI/SNF components; the **Runt domain** is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model.
GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding
ISS
GO_REF:0000024
ACCEPT
Summary: RNA polymerase II transcription regulatory region sequence-specific DNA binding is supported by RUNX3 Runt-domain sequence-specific DNA binding.
Reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor function.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)** and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761.
GO:0000122 negative regulation of transcription by RNA polymerase II
ISS
GO_REF:0000024
ACCEPT
Summary: Negative regulation of transcription by RNA polymerase II is supported for RUNX3 in repressive target-gene and Wnt/TCF contexts.
Reason: RUNX3 can repress transcriptional outputs through protein complexes and target-gene regulation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
PMID:18772112
Here we found that RUNX3, a gastric tumor suppressor, forms a ternary complex with beta-catenin/TCF4 and attenuates Wnt signaling activity.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
ISS
GO_REF:0000024
ACCEPT
Summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the best-supported core molecular function of RUNX3.
Reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0048935 peripheral nervous system neuron development
TAS
PMID:20096094
Brn3a regulates neuronal subtype specification in the trigem...
KEEP AS NON CORE
Summary: peripheral nervous system neuron development is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0005634 nucleus
IDA
PMID:20100835
Src kinase phosphorylates RUNX3 at tyrosine residues and loc...
ACCEPT
Summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
Reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
Because RUNX3 is a transcription factor, **nuclear localization** is essential for its canonical function. A recurring cancer mechanism is **functional inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional regulation).
GO:0006468 protein phosphorylation
IDA
PMID:20100835
Src kinase phosphorylates RUNX3 at tyrosine residues and loc...
REMOVE
Summary: Protein phosphorylation is not supported as a process carried out by RUNX3.
Reason: The cited biology describes Src-mediated phosphorylation of RUNX3, making RUNX3 the substrate rather than the kinase or causal gene product for protein phosphorylation.
Supporting Evidence:
PMID:20100835
In this study, we found that the overexpression of Src results in the tyrosine phosphorylation and cytoplasmic localization of RUNX3.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
GO:0005515 protein binding
IPI
PMID:20100835
Src kinase phosphorylates RUNX3 at tyrosine residues and loc...
MARK AS OVER ANNOTATED
Summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the main function.
Reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and chromatin factors, but the unqualified protein binding term is not informative for curation.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
A key 2023 advance demonstrated a **direct protein–protein mechanism** linking RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation of MYC.
GO:0005737 cytoplasm
IDA
PMID:20100835
Src kinase phosphorylates RUNX3 at tyrosine residues and loc...
KEEP AS NON CORE
Summary: cytoplasm localization is supported, but mainly as a mislocalization/export or degradation context rather than the canonical site of RUNX3 function.
Reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic localization is best treated as a regulated non-core or inactivation-associated state.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
file:human/RUNX3/RUNX3-deep-research-falcon.md
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss.
GO:0045786 negative regulation of cell cycle
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: negative regulation of cell cycle is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0050680 negative regulation of epithelial cell proliferation
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: negative regulation of epithelial cell proliferation is consistent with RUNX3 developmental or disease-associated transcriptional programs but is not the core molecular function.
Reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of RUNX3 transcription factor activity and should not be treated as the core function itself.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
**RUNX3 is a master developmental transcription factor** whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).
file:human/RUNX3/RUNX3-deep-research-falcon.md
A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter hypermethylation, histone modifications, and mislocalization**.
GO:0003700 DNA-binding transcription factor activity
TAS
PMID:7607690
Identification of a new murine runt domain-containing gene, ...
MODIFY
Summary: Generic DNA-binding transcription factor activity is correct but less precise than the RNA polymerase II-specific term already present.
Reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the more specific term is preferred.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
GO:0005524 ATP binding
NAS
PMID:7835892
AML1, AML2, and AML3, the human members of the runt domain g...
REMOVE
Summary: ATP binding is not supported as a RUNX3 molecular function.
Reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
GO:0006355 regulation of DNA-templated transcription
NAS
PMID:7622058
Cloning, mapping and expression of PEBP2 alpha C, a third ge...
MODIFY
Summary: Generic regulation of DNA-templated transcription is supported but should be captured with the RNA polymerase II-specific process.
Reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA polymerase II.
Supporting Evidence:
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
file:human/RUNX3/RUNX3-deep-research-falcon.md
RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).

Core Functions

Nuclear Runt-domain sequence-specific transcription factor activity in CBFβ/core-binding factor complexes, regulating RNA polymerase II target-gene programs through chromatin and regulatory-region DNA binding.

Supporting Evidence:
  • file:human/RUNX3/RUNX3-deep-research-falcon.md
    RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its primary function is as a **sequence-specific DNA-binding transcription factor** that regulates gene expression programs by binding target regulatory elements via the **Runt domain**, typically stabilized by heterodimerization with **CBFβ**.
  • file:human/RUNX3/RUNX3-deep-research-falcon.md
    RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity.
  • file:human/RUNX3/RUNX3-deep-research-falcon.md
    RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
  • file:human/RUNX3/RUNX3-deep-research-falcon.md
    RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization** can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Gene Ontology annotation of human sequence-specific DNA binding transcription factors (DbTFs) based on the TFClass database
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.
RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Brn3a regulates neuronal subtype specification in the trigeminal ganglion by promoting Runx expression during sensory differentiation.
Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.
The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.
Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
Impact of cytosine methylation on DNA binding specificities of human transcription factors.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma.
Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter.
Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain.
AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization.
Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.
Reactome:R-HSA-8865454
CBFB binds RUNX3
Reactome:R-HSA-8878117
RUNX3 binds ZFHX3
Reactome:R-HSA-8878143
RUNX3 binds SMAD3 and SMAD4
Reactome:R-HSA-8878178
The complex of RUNX3, SMAD3 and SMAD4 binds the CDKN1A gene promoter
Reactome:R-HSA-8878193
RUNX3 binds the JAG1 gene promoter
Reactome:R-HSA-8878220
RUNX3 binds the NOTCH1 coactivator complex
Reactome:R-HSA-8878237
RUNX3:NOTCH1 coactivator complex binds the HES1 gene promoter
Reactome:R-HSA-8937792
RUNX3 binds SRC
Reactome:R-HSA-8937807
SRC phosphorylates RUNX3
Reactome:R-HSA-8937814
RUNX3 translocates to the nucleus
Reactome:R-HSA-8949335
RUNX3:CBFB binds the ITGAL gene,(ITGA4 gene) promoter
Reactome:R-HSA-8951428
RUNX3 binds CTNNB1:TCF7L2,(LEF1,TCF7L1,TCF7)
Reactome:R-HSA-8951676
RUNX3 binds TEADs and YAP1
Reactome:R-HSA-8951910
RUNX3 binds the RUNX1 promoter
Reactome:R-HSA-8951951
RUNX3 binds EP300
Reactome:R-HSA-8951966
EP300 acetylates RUNX3
Reactome:R-HSA-8951977
Acetylated RUNX3 binds to BRD2
Reactome:R-HSA-8952058
CCND1 binds RUNX3 and displaces EP300
Reactome:R-HSA-8952062
CCND1 recruits HDAC4 to RUNX3
Reactome:R-HSA-8952069
HDAC4 deacetylates RUNX3
Reactome:R-HSA-8952128
RUNX3 binds TP53
Reactome:R-HSA-8952226
RUNX3 binds the BCL2L11 (BIM) gene
Reactome:R-HSA-8952371
MDM2 binds RUNX3
Reactome:R-HSA-8952382
MDM2 polyubiquitinates RUNX3
Reactome:R-HSA-8952399
Polyubiquitinated RUNX3 translocates to the cytosol
Reactome:R-HSA-8952408
Polyubiquitinated RUNX3 is degraded by the proteasome
Reactome:R-HSA-8952419
SMURFs ubiquitinate RUNX3
file:human/RUNX3/RUNX3-deep-research-falcon.md
Falcon deep research synthesis for RUNX3

Deep Research

Falcon

(RUNX3-deep-research-falcon.md)
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 46 citations 2026-05-12T00:59:19.684433

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: Human RUNX3 (UniProt Q13761)

Scope and identity verification (critical)

The target protein is human RUNX3 (gene symbol RUNX3, UniProt Q13761), described in UniProt as Runt-related transcription factor 3 with a conserved Runt (AML1_Runt) DNA-binding domain and C-terminal RUNX interaction region. In the literature retrieved here, the entity called RUNX3 is consistently described as a Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β) and regulates gene expression through sequence-specific DNA binding—matching the defining biochemical/structural properties expected for UniProt Q13761. However, within the retrieved full-text sources, the UniProt accession “Q13761” is not explicitly mentioned, so mapping is based on concordance of gene/protein name, organism (human), and domain/function description rather than a direct accession cross-reference. (chen2024runxtranscriptionfactors pages 1-2, mahmoud2024runx3actsas pages 6-8)

1) Key concepts and definitions (current understanding)

1.1 RUNX3 as a Runt-domain transcription factor and CBF complex component

RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors defined by a conserved Runt DNA-binding domain; they functionally heterodimerize with CBFβ, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and modulates transcriptional activity. This “core-binding factor” logic is foundational for interpreting RUNX3 function as a transcriptional regulator rather than an enzyme or transporter. (chen2024runxtranscriptionfactors pages 1-2)

1.2 RUNX3 molecular function: transcriptional regulation plus chromatin-linked activities

Beyond “transcription factor” as a label, recent mechanistic work supports RUNX3 as a chromatin-associated regulator with features often attributed to pioneer/chromatin-binding factors:
- RUNX3 can bind DNA and mononucleosomes, and RUNX3 loss alters chromatin accessibility and transcriptional programs (ATAC-seq/RNA-seq integration). (mahmoud2024runx3actsas pages 36-38, mahmoud2024runx3actsas pages 38-43)
- RUNX3 associates with CBFβ and chromatin remodeler machinery including SWI/SNF components; the Runt domain is implicated as critical for interactions with chromatin factors in this metastatic gastric cancer model. (mahmoud2024runx3actsas pages 6-8, mahmoud2024runx3actsas pages 38-43)

1.3 Subcellular localization as a functional control point

Because RUNX3 is a transcription factor, nuclear localization is essential for its canonical function. A recurring cancer mechanism is functional inactivation by cytoplasmic mislocalization (i.e., preventing nuclear transcriptional regulation). RUNX3 mislocalization is not merely correlative: oxidative stress can actively shift RUNX3 from nucleus to cytoplasm via a defined pathway (HDAC1/G9a→Src→RUNX3 phosphorylation→JAB1/CRM1-mediated export), coupled to proteasomal loss. (kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13)

2) Recent developments and latest research (prioritizing 2023–2024)

2.1 A 2023 mechanistic advance: RUNX3 directly destabilizes oncogenic MYC

A key 2023 advance demonstrated a direct protein–protein mechanism linking RUNX3 to oncogene control: RUNX3 binds MYC directly via the Runt domain, disrupts MYC’s transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases GSK3β-mediated phosphorylation of MYC at T58, and promotes FBXW7-dependent K48-linked ubiquitination and proteasomal degradation of MYC. This provides a concrete molecular basis for tumor-suppressive activity in contexts where MYC is a driver. (oei2023runx3inactivatesoncogenic pages 1-2, oei2023runx3inactivatesoncogenic pages 4-7, oei2023runx3inactivatesoncogenic pages 7-9, oei2023runx3inactivatesoncogenic pages 9-11)

Quantitative kinetic evidence was provided in cell systems: RUNX3 expression shortened MYC half-life (e.g., ~30→20 minutes in one system and ~32→23 minutes in another), supporting rapid post-translational control. (oei2023runx3inactivatesoncogenic pages 4-7)

2.2 2024: RUNX3 regulation by stress/epigenetic enzymes and mislocalization (oxidative stress → inactivation)

A 2024 study elucidated a pathway by which oxidative stress in colon cancer cells induces RUNX3 inactivation by nuclear export and cytoplasmic accumulation, integrating chromatin-modifier activity with signaling:
- Oxidative stress increased HDAC1 and G9a/EHMT2 and activated Src, resulting in RUNX3 tyrosine phosphorylation.
- RUNX3 interacted with JAB1 and CRM1, promoting CRM1-dependent export and proteasome-mediated depletion; JAB1 knockdown or CRM1 inhibition restored nuclear RUNX3.
This provides a mechanistic explanation for the often-cited phenomenon of RUNX3 cytoplasmic mislocalization as a route to functional loss. (kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13)

2.3 2024: post-translational downregulation by ubiquitin ligase MEX3C in lung adenocarcinoma

A 2024 translational mechanistic study in lung adenocarcinoma (LUAD) reported that the RNA-binding E3 ligase MEX3C promotes tumor phenotypes by ubiquitylating and degrading RUNX3 (protein-level regulation without corresponding mRNA change). The same study supports a downstream transcriptional axis where RUNX3 represses Suv39H1, positioning MEX3C→RUNX3↓→Suv39H1↑ as a tumor-promoting pathway. (he2024ubiquitylationofrunx3 pages 9-11, he2024ubiquitylationofrunx3 pages 11-15)

2.4 2024: RUNX3 can be contextually pro-metastatic in gastric cancer via WNT5A and developmental programs

A 2024 study (Cancer Research Communications) presented evidence that RUNX3 can be pro-metastatic in a gastric cancer model (HGC-27), where CRISPR KO reduced migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo. Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of metastasis-associated targets including WNT5A, CD44, and VIM, with WNT5A functioning as a major effector. This highlights a key modern theme: RUNX3 can act as tumor suppressor or oncogenic driver depending on cellular context and regulatory state. (suda2024aberrantupregulationof pages 5-8, suda2024aberrantupregulationof pages 8-10, suda2024aberrantupregulationof pages 1-2, suda2024aberrantupregulationof pages 10-11)

2.5 2024 review synthesis: RUNX3 intersects canonical signaling pathways (TGF-β/SMAD; Wnt; Hippo)

A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator embedded in major cancer-relevant pathways, including TGF-β/SMAD, Wnt/β-catenin, and Hippo–YAP crosstalk, and emphasizes frequent RUNX3 inactivation through promoter hypermethylation, histone modifications, and mislocalization. (chen2024runxtranscriptionfactors pages 1-2, chen2024runxtranscriptionfactors pages 18-19)

Within TGF-β signaling specifically, the 2024 review cites contexts where RUNX3 overexpression suppresses Smad2/3 phosphorylation and inhibits TGF-β/Smad-driven EMT and invasion, while also noting context-dependence (e.g., SMAD4/Dpc4 status in pancreatic cancer). (chen2024runxtranscriptionfactors pages 12-14)

3) Current applications and real-world implementations

3.1 Immunotherapy sensitization via RUNX3 epigenetic reprogramming (clinical translational mechanism)

A 2023 Molecular Cancer study connects RUNX3 to a clinically relevant immunotherapy strategy: decitabine (DNA-demethylating agent) priming can demethylate the RUNX3 promoter in CD8+ T cells, increase RUNX3 expression, promote CD8+ infiltration, and reduce exhaustion; crucially, conditional Runx3 loss in T cells abrogated the benefit of decitabine as a sensitizer for anti-PD-1 therapy in mouse models. (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 9-12, liu2023epigeneticreprogrammingof pages 7-9)

This work explicitly reports clinically relevant response statistics (from prior clinical work cited within the paper): combining low-dose decitabine with PD-1 blockade increased complete response in classical Hodgkin lymphoma from 32% to 71%. (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4)

3.2 Real-world engineered cell therapy: RUNX3-coexpressing CAR-T (phase I trial)

A direct “real-world implementation” of RUNX3 biology is its use as an engineered transcription factor cargo in CAR-T products. Fu et al. reported a first-in-human, single-center, single-arm phase I trial (NCT03980288) of CT017, a GPC3-targeting CAR T cell product that co-expresses RUNX3 (via an F2A peptide) for heavily pretreated, GPC3+ hepatocellular carcinoma. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 2-3)

Key clinical statistics:
- N=6 evaluable patients (7 infusions; one patient treated twice); dose 250×10^6 cells. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 5-6)
- Safety: cytokine release syndrome (CRS) occurred in all patients; 3/6 grade 3 CRS; no ICANS observed; CRS resolved. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 6-7, fu2023runx3expressingcart media 6458455b)
- Efficacy: ORR 16.7% (1 partial response) and DCR 50% (PR+SD); median PFS 3.5 months; median OS 7.9 months. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 7-8)
- Persistence: CAR-GPC3 DNA peaked around day 7 and was detectable at day 28, with reported persistence duration (median ~34 days). (fu2023runx3expressingcart pages 6-7, fu2023runx3expressingcart media 006d89ce)

(Visual evidence supporting the above endpoints is available in the trial’s Table/Figure crops.) (fu2023runx3expressingcart media 6458455b, fu2023runx3expressingcart media 006d89ce, fu2023runx3expressingcart media 9604a628)

4) Expert opinions and authoritative analysis (2023–2024 emphasis)

4.1 Consensus themes from recent reviews

Recent reviews converge on several expert-level interpretations:
1. RUNX3 is a master developmental transcription factor whose dysregulation can impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.). (chen2024runxtranscriptionfactors pages 1-2, chen2024runxtranscriptionfactors pages 18-19)
2. RUNX3 exhibits context dependence, with the same factor acting as tumor suppressor or tumor promoter depending on tumor type, stage, co-mutations, and signaling context. (chen2024runxtranscriptionfactors pages 18-19, chen2024runxtranscriptionfactors pages 12-14, suda2024aberrantupregulationof pages 5-8)
3. Non-genetic mechanisms—promoter hypermethylation, histone/chromatin changes, and protein mislocalization—are repeatedly emphasized as major routes to RUNX3 functional loss, often more prominent than coding mutations. (chen2024runxtranscriptionfactors pages 1-2, kang2024oxidativestressmediatedrunx3 pages 4-9)

4.2 RUNX3 as a Hippo pathway brake via TEAD competition

A 2023 gastric cancer Hippo-pathway review specifically highlights a downstream mechanism in which factors including RUNX3 can bind TEAD and antagonize YAP–TEAD interaction via competitive binding dynamics, positioning RUNX3 as a negative regulator of oncogenic YAP/TEAD transcriptional output in relevant contexts. (messina2023hippopathwaydysregulation pages 2-3, messina2023hippopathwaydysregulation pages 10-11)

5) Relevant statistics and data from recent studies

5.1 Human cohort/clinical data examples (2023–2024)

  • RUNX3 epigenetic immunotherapy link (2023): cited clinical improvement with DAC+anti-PD-1 in cHL from 32% to 71% complete response; multiomic profiling included methylation arrays with 829,120 CpGs in 25 samples after QC and expression validation in 48 patients for qRT-PCR. (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 4-5)
  • RUNX3-engineered CAR-T phase I in HCC (2023): N=6 evaluable; ORR 16.7%, DCR 50%; CRS grade 3 in 3/6; no ICANS; median PFS 3.5 months; median OS 7.9 months. (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 7-8, fu2023runx3expressingcart pages 6-7, fu2023runx3expressingcart media 6458455b)
  • MEX3C–RUNX3 axis in LUAD (2024): clinical paired-sample cohort n=55; negative mRNA correlation (r≈−0.615, p<0.0001) between MEX3C and RUNX3; xenograft/metastasis animal experiments reported n=5/group. (he2024ubiquitylationofrunx3 pages 11-15, he2024ubiquitylationofrunx3 pages 6-9)
  • Gastric metastasis program (2024): tumor immunofluorescence correlation between RUNX3 and WNT5A in cancer cells reported in resected tumors (n=35, r≈0.474, P<0.01). (suda2024aberrantupregulationof pages 11-13)

5.2 Disease-association landscape (database summary)

Open Targets links RUNX3 to immune/allergic disease phenotypes (e.g., asthma, psoriasis, allergic rhinitis, eczematoid dermatitis) with moderate association scores and supporting literature evidence counts, consistent with RUNX3’s known roles in immune cell differentiation and tissue inflammation. (OpenTargets Search: -RUNX3)


Functional annotation summary (what RUNX3 “does,” where it acts, and pathways)

Primary molecular role

RUNX3 is not an enzyme and does not catalyze a chemical reaction; its primary function is as a sequence-specific DNA-binding transcription factor that regulates gene expression programs by binding target regulatory elements via the Runt domain, typically stabilized by heterodimerization with CBFβ. (chen2024runxtranscriptionfactors pages 1-2)

Where RUNX3 acts in the cell

RUNX3’s canonical site of action is the nucleus, where it binds chromatin and regulates transcription. Multiple studies emphasize that cytoplasmic mislocalization can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery. (kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13)

Pathway-level roles (mechanistic examples)

  1. MYC control: RUNX3 binds MYC and triggers phosphorylation-dependent ubiquitin-mediated MYC degradation via GSK3β–FBXW7. (oei2023runx3inactivatesoncogenic pages 1-2, oei2023runx3inactivatesoncogenic pages 7-9)
  2. TGF-β/SMAD: RUNX3 is repeatedly linked to TGF-β/Smad EMT regulation; review synthesis includes suppression of Smad2/3 phosphorylation and context dependence (e.g., SMAD4 status). (chen2024runxtranscriptionfactors pages 12-14)
  3. Hippo–YAP/TEAD: RUNX3 is cited as a TEAD-binding competitor that can inhibit YAP–TEAD complex formation and activity in gastric cancer–relevant Hippo pathway frameworks. (messina2023hippopathwaydysregulation pages 2-3, messina2023hippopathwaydysregulation pages 10-11)
  4. Noncanonical Wnt/metastasis program: in a gastric cancer model, RUNX3 directly activates WNT5A and other metastasis-related targets (CD44, VIM) using enhancer–promoter topology. (suda2024aberrantupregulationof pages 5-8, suda2024aberrantupregulationof pages 8-10)
  5. Immune differentiation and therapy response: RUNX3 promoter methylation status controls RUNX3 expression in CD8+ T cells, shaping infiltration/exhaustion and determining whether demethylating therapy can sensitize to PD-1 blockade. (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 9-12)

Summary table of mechanisms and applications

The following table consolidates RUNX3 identity, pathways, localization, and translational evidence, emphasizing 2023–2024 results and quantitative endpoints:

Aspect Summary for human RUNX3 (UniProt Q13761) Representative recent study / quantitative detail
Molecular identity RUNX3 matches the human Runt-related transcription factor 3 described for UniProt Q13761; RUNX proteins are sequence-specific transcription factors with a conserved Runt DNA-binding domain that heterodimerize with CBFβ, which stabilizes DNA binding and transcriptional function. RUNX3 is repeatedly discussed in cancer and immune literature as this CBFβ-partnered Runt-domain TF, consistent with the UniProt annotation and domain architecture (chen2024runxtranscriptionfactors pages 1-2, mahmoud2024runx3actsas pages 6-8). Chen et al., 2024-03, Clinical and Experimental Medicine, https://doi.org/10.1007/s10238-023-01281-0; Mahmoud et al., 2024-08, bioRxiv, https://doi.org/10.1101/2024.08.16.608297 (chen2024runxtranscriptionfactors pages 1-2, mahmoud2024runx3actsas pages 6-8)
Primary molecular functions RUNX3 functions as a DNA-binding transcriptional regulator and protein-interaction hub. Beyond canonical transcriptional control, recent work supports chromatin/pioneer-like activity: RUNX3 binds DNA and mononucleosomes, associates with SWI/SNF and other chromatin factors, and the Runt domain is required for interactions with chromatin remodelers. Proteomics identified 1,227 candidate interacting proteins, with enrichment for ATP-dependent chromatin remodeling; RUNX3 loss reduced SWI/SNF components and altered chromatin accessibility/transcriptional programs (mahmoud2024runx3actsas pages 6-8, mahmoud2024runx3actsas pages 36-38, mahmoud2024runx3actsas pages 38-43, mahmoud2024runx3actsas pages 24-26). Mahmoud et al., 2024-08, https://doi.org/10.1101/2024.08.16.608297; tissue array n=59, KM-plotter gastric cohort n=875; low vs high RUNX3 groups 526 vs 349, P=0.0002 (mahmoud2024runx3actsas pages 6-8, mahmoud2024runx3actsas pages 38-43)
TGF-β/SMAD axis RUNX3 is a major RUNX-family node in TGF-β signaling. Review-level synthesis indicates that RUNX3 overexpression can suppress Smad2/3 phosphorylation, inhibit TGF-β/Smad-driven EMT/invasion, and that loss of RUNX3 by hypermethylation is linked to metastatic progression. However, this role is context dependent; in pancreatic ductal adenocarcinoma, RUNX3 may restrain proliferation yet facilitate migration/invasion depending on SMAD4/Dpc4 status (chen2024runxtranscriptionfactors pages 12-14, chen2024runxtranscriptionfactors pages 17-18). Chen et al., 2024-03, https://doi.org/10.1007/s10238-023-01281-0 (chen2024runxtranscriptionfactors pages 12-14, chen2024runxtranscriptionfactors pages 17-18)
Hippo–YAP/TEAD axis RUNX3 is described as a negative regulator of the oncogenic TEAD–YAP complex. Recent reviews summarize that RUNX3 can bind TEAD competitively and antagonize YAP–TEAD transcriptional output, placing RUNX3 as a Hippo-pathway brake; gastric-cancer Hippo review cites RUNX3 among factors that inhibit YAP–TEAD interaction in a competitive dynamic (chen2024runxtranscriptionfactors pages 18-19, messina2023hippopathwaydysregulation pages 2-3, messina2023hippopathwaydysregulation pages 10-11). Messina et al., 2023-01, Cell Death & Disease, https://doi.org/10.1038/s41419-023-05568-8; Chen et al., 2024-03, https://doi.org/10.1007/s10238-023-01281-0 (chen2024runxtranscriptionfactors pages 18-19, messina2023hippopathwaydysregulation pages 2-3, messina2023hippopathwaydysregulation pages 10-11)
MYC control / tumor-suppressive protein interaction A 2023 mechanistic study showed RUNX3 directly binds MYC via the Runt domain, disrupts MYC–MAX and MYC–MIZ1 complexes, enhances GSK3β-mediated T58 phosphorylation, recruits FBXW7, and drives K48-linked ubiquitin-proteasomal MYC degradation. Interaction occurs mainly in the nucleus, and a Runt-domain mutant (R122C) loses this MYC-destabilizing activity (oei2023runx3inactivatesoncogenic pages 1-2, oei2023runx3inactivatesoncogenic pages 4-7, oei2023runx3inactivatesoncogenic pages 7-9, oei2023runx3inactivatesoncogenic pages 9-11). Oei et al., 2023-07, Communications Biology, https://doi.org/10.1038/s42003-023-05037-0; MYC half-life shortened from ~30→20 min in HeLa and ~32→23 min in MKN28 with RUNX3 expression (oei2023runx3inactivatesoncogenic pages 4-7)
Subcellular localization / inactivation RUNX3 is primarily a nuclear transcription factor, but cytoplasmic mislocalization is a recurrent inactivation mechanism in cancer. Oxidative stress can drive nuclear-to-cytoplasmic relocalization through HDAC1/G9a upregulation → Src activation → RUNX3 tyrosine phosphorylation → JAB1/CRM1-mediated export, with subsequent proteasomal degradation; NAC, HDAC1/G9a knockdown, JAB1 knockdown, or CRM1 inhibition restore nuclear RUNX3 (chen2024runxtranscriptionfactors pages 1-2, kang2024oxidativestressmediatedrunx3 pages 4-9, kang2024oxidativestressmediatedrunx3 pages 9-13, kang2024oxidativestressmediatedrunx3 pages 1-4). Kang et al., 2024-04, Applied Biochemistry and Biotechnology, https://doi.org/10.1007/s12010-024-04944-0; oxidative stress model used 100 μM H2O2 (kang2024oxidativestressmediatedrunx3 pages 4-9)
Post-translational downregulation by MEX3C In lung adenocarcinoma, the RNA-binding E3 ligase MEX3C binds RUNX3 and promotes RUNX3 ubiquitylation/proteasomal degradation, without materially changing RUNX3 mRNA. Downstream, RUNX3 represses Suv39H1; thus the MEX3C→RUNX3↓→Suv39H1↑ axis promotes proliferation, migration, invasion, EMT-like programs, and tumor growth/metastasis (he2024ubiquitylationofrunx3 pages 9-11, he2024ubiquitylationofrunx3 pages 11-15, he2024ubiquitylationofrunx3 pages 6-9). He et al., 2024-02, Journal of Translational Medicine, https://doi.org/10.1186/s12967-023-04700-8; clinical LUAD cohort n=55 paired tumors, MEX3C–RUNX3 mRNA correlation r = -0.6151, p < 0.0001; xenograft/metastasis assays reported n=5/group (he2024ubiquitylationofrunx3 pages 11-15, he2024ubiquitylationofrunx3 pages 15-18, he2024ubiquitylationofrunx3 pages 6-9)
WNT5A / gastric metastasis axis RUNX3 can also act pro-metastatically in gastric cancer. CRISPR KO in HGC-27 cells reduced migration, invasion, anchorage-independent growth, xenograft growth, and liver metastasis. Multi-omic mapping showed RUNX3 directly regulates metastasis/developmental genes including WNT5A, CD44, VIM, with ChIP-seq and HiChIP linking RUNX3-bound distal elements/promoters to these loci; WNT5A emerged as a main functional effector (suda2024aberrantupregulationof pages 5-8, suda2024aberrantupregulationof pages 8-10, suda2024aberrantupregulationof pages 1-2, suda2024aberrantupregulationof pages 11-13). Suda et al., 2024-02, Cancer Research Communications, https://doi.org/10.1158/2767-9764.crc-22-0165; resected tumor IF showed RUNX3–WNT5A correlation in cancer cells n=35, Pearson r = 0.4744, P < 0.01 (suda2024aberrantupregulationof pages 11-13)
CD8+ T-cell differentiation / immunotherapy RUNX3 is a key regulator of CD8+ T-cell differentiation, infiltration, effector/memory fate, and residency. In Hodgkin lymphoma immunotherapy studies, promoter P2 demethylation increased RUNX3 expression, promoted CD8+ TIL infiltration, reduced exhaustion, and was required for decitabine (DAC) to sensitize tumors to anti-PD-1; conditional Runx3 loss reduced effector/memory T cells and CCR3/CCR5 and abrogated DAC benefit (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 9-12, liu2023epigeneticreprogrammingof pages 7-9). Liu et al., 2023-05, Molecular Cancer, https://doi.org/10.1186/s12943-023-01768-0; low-dose DAC + anti-PD-1 increased complete response in cHL from 32% to 71%; prior PD-1 failures had 70% re-response and 28% CR; EPIC/RNA-seq high-throughput subset 10 samples; 829,120 CpGs in 25 samples after QC; qRT-PCR cohort 48 patients (liu2023epigeneticreprogrammingof pages 1-2, liu2023epigeneticreprogrammingof pages 2-4, liu2023epigeneticreprogrammingof pages 4-5)
Real-world implementation: RUNX3-engineered cell therapy RUNX3 has already been used in a first-in-human CAR-T implementation: CT017 co-expresses a GPC3 CAR and RUNX3 (via F2A peptide) to enhance tumor infiltration, persistence, and tissue-resident features. This is a real-world therapeutic implementation of RUNX3 biology in advanced hepatocellular carcinoma (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 2-3, fu2023runx3expressingcart pages 10-10). Fu et al., 2023-09, eClinicalMedicine, https://doi.org/10.1016/j.eclinm.2023.102175; phase I, N=6 evaluable, 1 PR + 2 SDORR 16.7%, DCR 50%, median PFS 3.5 mo, median OS 7.9 mo; all had CRS, 3/6 grade 3, no ICANS; CAR DNA peaked day 7, detectable median 34 days (fu2023runx3expressingcart pages 1-2, fu2023runx3expressingcart pages 7-8, fu2023runx3expressingcart pages 6-7, fu2023runx3expressingcart media 6458455b)
Biomarker / prognostic use Current expert opinion supports RUNX3 as a biomarker candidate rather than a routine standalone clinical marker. RUNX3 expression or pathway signatures have been associated with prognosis, immunotherapy response, and epigenetic state; reviews emphasize its potential value but also note strong tumor-context dependence and bidirectional roles in solid tumors (chen2024runxtranscriptionfactors pages 18-19, chen2024runxtranscriptionfactors pages 17-18, liu2023epigeneticreprogrammingof pages 12-14). Wang et al., 2024-01, BMC Urology, https://doi.org/10.1186/s12894-023-01356-w; in advanced RCC, high RUNX3 pathway signature associated with shorter PFS in two IO/TKI cohorts (P=0.025 and P=0.019) and correlated with fewer GZMB+ CD8+ T cells (ρ = -0.42, P=0.006) (liu2023epigeneticreprogrammingof pages 12-14)
Disease-association landscape Open Targets links RUNX3 to immune/allergic disease traits including asthma, psoriasis, allergic rhinitis, eczematoid dermatitis, supporting its broader immunoregulatory relevance beyond cancer, though evidence strength is moderate and disease-specific mechanisms vary (OpenTargets Search: -RUNX3). Open Targets association scores: asthma 0.5383, psoriasis 0.5274, allergic disease 0.5233, allergic rhinitis 0.4926, eczematoid dermatitis 0.4782 (OpenTargets Search: -RUNX3)

Table: This table condenses verified identity, mechanisms, localization, pathways, and translational evidence for human RUNX3 (UniProt Q13761). It is designed to support a comprehensive annotation narrative while highlighting key 2023–2024 studies and quantitative findings.

Figures/tables supporting clinical implementation evidence

  • CT017 trial safety table and CAR-T kinetics/response plots (cropped visual evidence). (fu2023runx3expressingcart media 6458455b, fu2023runx3expressingcart media 006d89ce, fu2023runx3expressingcart media 9604a628)

Limitations of this evidence set

  1. Direct UniProt accession linkage: none of the retrieved full texts explicitly mention “UniProt Q13761,” so accession-level verification is inferential (name/domain/organism concordance). (chen2024runxtranscriptionfactors pages 1-2)
  2. Context dependence: RUNX3 can act as tumor suppressor or promoter depending on tissue and regulatory context; mechanistic claims should therefore be interpreted within the experimental system described (e.g., LUAD vs gastric cancer metastasis models). (chen2024runxtranscriptionfactors pages 12-14, suda2024aberrantupregulationof pages 5-8)

Key references (publication date; URL)

  • Chen X et al. 2024-03. Clinical and Experimental Medicine. RUNX transcription factors: biological functions and implications in cancer. https://doi.org/10.1007/s10238-023-01281-0 (chen2024runxtranscriptionfactors pages 1-2)
  • Oei V et al. 2023-07. Communications Biology. RUNX3 inactivates oncogenic MYC via MYC/MAX disruption and GSK3β–FBXW7. https://doi.org/10.1038/s42003-023-05037-0 (oei2023runx3inactivatesoncogenic pages 1-2)
  • Kang KA et al. 2024-04. Applied Biochemistry and Biotechnology. Oxidative stress-mediated RUNX3 mislocalization via JAB1 and histone modification. https://doi.org/10.1007/s12010-024-04944-0 (kang2024oxidativestressmediatedrunx3 pages 4-9)
  • He Z et al. 2024-02. Journal of Translational Medicine. MEX3C ubiquitylates RUNX3 in LUAD. https://doi.org/10.1186/s12967-023-04700-8 (he2024ubiquitylationofrunx3 pages 11-15)
  • Suda K et al. 2024-02. Cancer Research Communications. RUNX3 upregulation drives gastric cancer metastasis via WNT5A. https://doi.org/10.1158/2767-9764.crc-22-0165 (suda2024aberrantupregulationof pages 5-8)
  • Liu Z et al. 2023-05. Molecular Cancer. RUNX3 epigenetic reprogramming reinforces CD8+ T cells and improves immunotherapy response. https://doi.org/10.1186/s12943-023-01768-0 (liu2023epigeneticreprogrammingof pages 1-2)
  • Fu Q et al. 2023-09. eClinicalMedicine. RUNX-3-expressing CAR-T cells targeting GPC3 in advanced HCC (phase I). https://doi.org/10.1016/j.eclinm.2023.102175 (fu2023runx3expressingcart pages 1-2)
  • Messina B et al. 2023-01. Cell Death & Disease. Hippo pathway dysregulation in gastric cancer; TEAD-binding competitors including RUNX3. https://doi.org/10.1038/s41419-023-05568-8 (messina2023hippopathwaydysregulation pages 2-3)
  • Open Targets Platform (retrieved via tool): RUNX3 disease associations (asthma/psoriasis/allergic traits). https://platform.opentargets.org/target/ENSG00000020633 (OpenTargets Search: -RUNX3)

References

  1. (chen2024runxtranscriptionfactors pages 1-2): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.

  2. (mahmoud2024runx3actsas pages 6-8): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.

  3. (mahmoud2024runx3actsas pages 36-38): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.

  4. (mahmoud2024runx3actsas pages 38-43): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.

  5. (kang2024oxidativestressmediatedrunx3 pages 4-9): Kyoung Ah Kang, Mei Jing Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Hye-Jin Boo, Sang Pil Yoon, and Jin Won Hyun. Oxidative stress-mediated runx3 mislocalization occurs via jun activation domain-binding protein 1 and histone modification. Applied Biochemistry and Biotechnology, 196:8082-8095, Apr 2024. URL: https://doi.org/10.1007/s12010-024-04944-0, doi:10.1007/s12010-024-04944-0. This article has 7 citations and is from a peer-reviewed journal.

  6. (kang2024oxidativestressmediatedrunx3 pages 9-13): Kyoung Ah Kang, Mei Jing Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Hye-Jin Boo, Sang Pil Yoon, and Jin Won Hyun. Oxidative stress-mediated runx3 mislocalization occurs via jun activation domain-binding protein 1 and histone modification. Applied Biochemistry and Biotechnology, 196:8082-8095, Apr 2024. URL: https://doi.org/10.1007/s12010-024-04944-0, doi:10.1007/s12010-024-04944-0. This article has 7 citations and is from a peer-reviewed journal.

  7. (oei2023runx3inactivatesoncogenic pages 1-2): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.

  8. (oei2023runx3inactivatesoncogenic pages 4-7): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.

  9. (oei2023runx3inactivatesoncogenic pages 7-9): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.

  10. (oei2023runx3inactivatesoncogenic pages 9-11): Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo, Supriya Srivastava, Ming Teh, and Yoshiaki Ito. Runx3 inactivates oncogenic myc through disruption of myc/max complex and subsequent recruitment of gsk3β-fbxw7 cascade. Communications Biology, Jul 2023. URL: https://doi.org/10.1038/s42003-023-05037-0, doi:10.1038/s42003-023-05037-0. This article has 5 citations and is from a peer-reviewed journal.

  11. (he2024ubiquitylationofrunx3 pages 9-11): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.

  12. (he2024ubiquitylationofrunx3 pages 11-15): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.

  13. (suda2024aberrantupregulationof pages 5-8): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.

  14. (suda2024aberrantupregulationof pages 8-10): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.

  15. (suda2024aberrantupregulationof pages 1-2): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.

  16. (suda2024aberrantupregulationof pages 10-11): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.

  17. (chen2024runxtranscriptionfactors pages 18-19): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.

  18. (chen2024runxtranscriptionfactors pages 12-14): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.

  19. (liu2023epigeneticreprogrammingof pages 1-2): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.

  20. (liu2023epigeneticreprogrammingof pages 2-4): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.

  21. (liu2023epigeneticreprogrammingof pages 9-12): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.

  22. (liu2023epigeneticreprogrammingof pages 7-9): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.

  23. (fu2023runx3expressingcart pages 1-2): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  24. (fu2023runx3expressingcart pages 2-3): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  25. (fu2023runx3expressingcart pages 5-6): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  26. (fu2023runx3expressingcart pages 6-7): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  27. (fu2023runx3expressingcart media 6458455b): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  28. (fu2023runx3expressingcart pages 7-8): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  29. (fu2023runx3expressingcart media 006d89ce): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  30. (fu2023runx3expressingcart media 9604a628): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  31. (messina2023hippopathwaydysregulation pages 2-3): Beatrice Messina, Federica Lo Sardo, Stefano Scalera, Lorenzo Memeo, Cristina Colarossi, Marzia Mare, Giovanni Blandino, Gennaro Ciliberto, Marcello Maugeri-Saccà, and Giulia Bon. Hippo pathway dysregulation in gastric cancer: from helicobacter pylori infection to tumor promotion and progression. Cell Death & Disease, Jan 2023. URL: https://doi.org/10.1038/s41419-023-05568-8, doi:10.1038/s41419-023-05568-8. This article has 67 citations and is from a peer-reviewed journal.

  32. (messina2023hippopathwaydysregulation pages 10-11): Beatrice Messina, Federica Lo Sardo, Stefano Scalera, Lorenzo Memeo, Cristina Colarossi, Marzia Mare, Giovanni Blandino, Gennaro Ciliberto, Marcello Maugeri-Saccà, and Giulia Bon. Hippo pathway dysregulation in gastric cancer: from helicobacter pylori infection to tumor promotion and progression. Cell Death & Disease, Jan 2023. URL: https://doi.org/10.1038/s41419-023-05568-8, doi:10.1038/s41419-023-05568-8. This article has 67 citations and is from a peer-reviewed journal.

  33. (liu2023epigeneticreprogrammingof pages 4-5): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.

  34. (he2024ubiquitylationofrunx3 pages 6-9): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.

  35. (suda2024aberrantupregulationof pages 11-13): Kazuto Suda, Atsushi Okabe, Junichi Matsuo, Linda Shyue Huey Chuang, Ying Li, Nawaphat Jangphattananont, Naing Naing Mon, Khine Nyein Myint, Akihiro Yamamura, Jimmy Bok-Yan So, Dominic Chih-Cheng Voon, Henry Yang, Khay Guan Yeoh, Atsushi Kaneda, and Yoshiaki Ito. Aberrant upregulation of runx3 activates developmental genes to drive metastasis in gastric cancer. Cancer Research Communications, 4:279-292, Feb 2024. URL: https://doi.org/10.1158/2767-9764.crc-22-0165, doi:10.1158/2767-9764.crc-22-0165. This article has 7 citations and is from a peer-reviewed journal.

  36. (OpenTargets Search: -RUNX3): Open Targets Query (-RUNX3, 6 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  37. (mahmoud2024runx3actsas pages 24-26): Salma Awad Mahmoud, Isabelle Bonne, Aik Yong Sim, and Gehan Labib Abuelenain. Runx3 acts as homodimeric chromatin binding factor regulating heterochromatin-mediated cancerous phenotype. bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.08.16.608297, doi:10.1101/2024.08.16.608297. This article has 1 citations.

  38. (chen2024runxtranscriptionfactors pages 17-18): Xinyi Chen, Lu Wang, Mu Yang, Weiheng Zhao, Jingyao Tu, Bo Liu, and Xianglin Yuan. Runx transcription factors: biological functions and implications in cancer. Clinical and Experimental Medicine, Mar 2024. URL: https://doi.org/10.1007/s10238-023-01281-0, doi:10.1007/s10238-023-01281-0. This article has 17 citations and is from a peer-reviewed journal.

  39. (kang2024oxidativestressmediatedrunx3 pages 1-4): Kyoung Ah Kang, Mei Jing Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Hye-Jin Boo, Sang Pil Yoon, and Jin Won Hyun. Oxidative stress-mediated runx3 mislocalization occurs via jun activation domain-binding protein 1 and histone modification. Applied Biochemistry and Biotechnology, 196:8082-8095, Apr 2024. URL: https://doi.org/10.1007/s12010-024-04944-0, doi:10.1007/s12010-024-04944-0. This article has 7 citations and is from a peer-reviewed journal.

  40. (he2024ubiquitylationofrunx3 pages 15-18): Zelai He, Huijun Zhang, Hai-bo Xiao, Xiangyu Zhang, Hongbo Xu, Ruifen Sun, and Siwen Li. Ubiquitylation of runx3 by rna-binding ubiquitin ligase mex3c promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine, Feb 2024. URL: https://doi.org/10.1186/s12967-023-04700-8, doi:10.1186/s12967-023-04700-8. This article has 10 citations and is from a peer-reviewed journal.

  41. (fu2023runx3expressingcart pages 10-10): Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, You Zhai, Zhou Tong, Hangyu Zhang, Meihua Lin, Xudong Zhu, Huamao Wang, Yumeng Wang, Zhen Liu, Daijing Yuan, Xuanwen Bao, Wanwan Gao, Xiaomeng Dai, Zonghai Li, and Tingbo Liang. Runx-3-expressing car t cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase i trial. eClinicalMedicine, 63:102175, Sep 2023. URL: https://doi.org/10.1016/j.eclinm.2023.102175, doi:10.1016/j.eclinm.2023.102175. This article has 69 citations and is from a peer-reviewed journal.

  42. (liu2023epigeneticreprogrammingof pages 12-14): Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, and Yingli Sun. Epigenetic reprogramming of runx3 reinforces cd8 + t-cell function and improves the clinical response to immunotherapy. Molecular Cancer, May 2023. URL: https://doi.org/10.1186/s12943-023-01768-0, doi:10.1186/s12943-023-01768-0. This article has 56 citations and is from a highest quality peer-reviewed journal.

Citations

  1. chen2024runxtranscriptionfactors pages 1-2
  2. chen2024runxtranscriptionfactors pages 12-14
  3. suda2024aberrantupregulationof pages 11-13
  4. liu2023epigeneticreprogrammingof pages 12-14
  5. suda2024aberrantupregulationof pages 5-8
  6. liu2023epigeneticreprogrammingof pages 1-2
  7. messina2023hippopathwaydysregulation pages 2-3
  8. suda2024aberrantupregulationof pages 8-10
  9. suda2024aberrantupregulationof pages 1-2
  10. suda2024aberrantupregulationof pages 10-11
  11. chen2024runxtranscriptionfactors pages 18-19
  12. liu2023epigeneticreprogrammingof pages 2-4
  13. liu2023epigeneticreprogrammingof pages 9-12
  14. liu2023epigeneticreprogrammingof pages 7-9
  15. messina2023hippopathwaydysregulation pages 10-11
  16. liu2023epigeneticreprogrammingof pages 4-5
  17. chen2024runxtranscriptionfactors pages 17-18
  18. https://doi.org/10.1007/s10238-023-01281-0;
  19. https://doi.org/10.1101/2024.08.16.608297
  20. https://doi.org/10.1101/2024.08.16.608297;
  21. https://doi.org/10.1007/s10238-023-01281-0
  22. https://doi.org/10.1038/s41419-023-05568-8;
  23. https://doi.org/10.1038/s42003-023-05037-0;
  24. https://doi.org/10.1007/s12010-024-04944-0;
  25. https://doi.org/10.1186/s12967-023-04700-8;
  26. https://doi.org/10.1158/2767-9764.crc-22-0165;
  27. https://doi.org/10.1186/s12943-023-01768-0;
  28. https://doi.org/10.1016/j.eclinm.2023.102175;
  29. https://doi.org/10.1186/s12894-023-01356-w;
  30. https://doi.org/10.1038/s42003-023-05037-0
  31. https://doi.org/10.1007/s12010-024-04944-0
  32. https://doi.org/10.1186/s12967-023-04700-8
  33. https://doi.org/10.1158/2767-9764.crc-22-0165
  34. https://doi.org/10.1186/s12943-023-01768-0
  35. https://doi.org/10.1016/j.eclinm.2023.102175
  36. https://doi.org/10.1038/s41419-023-05568-8
  37. https://platform.opentargets.org/target/ENSG00000020633
  38. https://doi.org/10.1007/s10238-023-01281-0,
  39. https://doi.org/10.1101/2024.08.16.608297,
  40. https://doi.org/10.1007/s12010-024-04944-0,
  41. https://doi.org/10.1038/s42003-023-05037-0,
  42. https://doi.org/10.1186/s12967-023-04700-8,
  43. https://doi.org/10.1158/2767-9764.crc-22-0165,
  44. https://doi.org/10.1186/s12943-023-01768-0,
  45. https://doi.org/10.1016/j.eclinm.2023.102175,
  46. https://doi.org/10.1038/s41419-023-05568-8,

📄 View Raw YAML

id: Q13761
gene_symbol: RUNX3
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: 'RUNX3 encodes Runt-related transcription factor 3, a nuclear Runt-domain DNA-binding transcription
  factor that heterodimerizes with CBFβ/core-binding factor complexes to regulate RNA polymerase II target-gene
  programs. Its core function is sequence-specific regulatory DNA and chromatin binding for context-dependent
  transcriptional activation or repression, with important downstream roles in development, TGF-beta/Wnt/Hippo
  signaling, CD8 T-cell biology, and cancer-associated mislocalization or degradation.'
existing_annotations:
- term:
    id: GO:0000978
    label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: RNA polymerase II cis-regulatory region sequence-specific DNA binding is supported by
      RUNX3 Runt-domain sequence-specific DNA binding.
    action: ACCEPT
    reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
      function.
    supported_by: &id003
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
        primary function is as a **sequence-specific DNA-binding transcription factor** that
        regulates gene expression programs by binding target regulatory elements via the **Runt
        domain**, typically stabilized by heterodimerization with **CBFβ**.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: The target protein is **human RUNX3** (gene symbol **RUNX3**, UniProt
        **Q13761**), described in UniProt as *Runt-related transcription factor 3* with a conserved
        **Runt (AML1_Runt) DNA-binding domain** and C-terminal RUNX interaction region. In the
        literature retrieved here, the entity called RUNX3 is consistently described as a
        **Runt-domain transcription factor that heterodimerizes with CBFβ (core-binding factor β)**
        and regulates gene expression through sequence-specific DNA binding—matching the defining
        biochemical/structural properties expected for UniProt Q13761.
- term:
    id: GO:0001503
    label: ossification
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ossification is consistent with RUNX3 developmental or disease-associated
      transcriptional programs but is not the core molecular function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: &id001
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: '**RUNX3 is a master developmental transcription factor** whose dysregulation can
        impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).'
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator
        embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and
        **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter
        hypermethylation, histone modifications, and mislocalization**.
- term:
    id: GO:0030097
    label: hemopoiesis
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: hemopoiesis is consistent with RUNX3 developmental or disease-associated
      transcriptional programs but is not the core molecular function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: *id001
- term:
    id: GO:0030182
    label: neuron differentiation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: neuron differentiation is consistent with RUNX3 developmental or disease-associated
      transcriptional programs but is not the core molecular function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: *id001
- term:
    id: GO:0045595
    label: regulation of cell differentiation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: regulation of cell differentiation is consistent with RUNX3 developmental or
      disease-associated transcriptional programs but is not the core molecular function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: *id001
- term:
    id: GO:0006357
    label: regulation of transcription by RNA polymerase II
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
    action: ACCEPT
    reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription
      factor.
    supported_by: &id002
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
        primary function is as a **sequence-specific DNA-binding transcription factor** that
        regulates gene expression programs by binding target regulatory elements via the **Runt
        domain**, typically stabilized by heterodimerization with **CBFβ**.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
        defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
        CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
        modulates transcriptional activity.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin
        accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the
      best-supported core molecular function of RUNX3.
    action: ACCEPT
    reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA
      polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
    supported_by: *id002
- term:
    id: GO:0002062
    label: chondrocyte differentiation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: chondrocyte differentiation is consistent with RUNX3 developmental or
      disease-associated transcriptional programs but is not the core molecular function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: *id001
- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Generic DNA binding is directionally correct but less precise than RUNX3
      sequence-specific regulatory DNA binding.
    action: MODIFY
    reason: RUNX3 is not merely a generic DNA-binding protein; its supported molecular role is
      sequence-specific Runt-domain binding at regulatory regions.
    proposed_replacement_terms:
    - id: GO:1990837
      label: sequence-specific double-stranded DNA binding
    - id: GO:0000978
      label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
    supported_by: *id003
- term:
    id: GO:0003700
    label: DNA-binding transcription factor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Generic DNA-binding transcription factor activity is correct but less precise than the
      RNA polymerase II-specific term already present.
    action: MODIFY
    reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the
      more specific term is preferred.
    proposed_replacement_terms: &id010
    - id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase II-specific
    supported_by: *id002
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: ATP binding is not supported as a RUNX3 molecular function.
    action: REMOVE
    reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent
      chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
    supported_by: &id011
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
        primary function is as a **sequence-specific DNA-binding transcription factor** that
        regulates gene expression programs by binding target regulatory elements via the **Runt
        domain**, typically stabilized by heterodimerization with **CBFβ**.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: &id005
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
        and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
        can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides
        a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export
        machinery.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: Because RUNX3 is a transcription factor, **nuclear localization** is
        essential for its canonical function. A recurring cancer mechanism is **functional
        inactivation by cytoplasmic mislocalization** (i.e., preventing nuclear transcriptional
        regulation).
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: cytoplasm localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: &id006
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
        and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
        can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides
        a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export
        machinery.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: This provides a mechanistic explanation for the often-cited phenomenon of
        RUNX3 cytoplasmic mislocalization as a route to functional loss.
- term:
    id: GO:0006355
    label: regulation of DNA-templated transcription
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Generic regulation of DNA-templated transcription is supported but should be captured
      with the RNA polymerase II-specific process.
    action: MODIFY
    reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA
      polymerase II.
    proposed_replacement_terms: &id012
    - id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    supported_by: *id002
- term:
    id: GO:0045893
    label: positive regulation of DNA-templated transcription
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: Positive regulation of DNA-templated transcription is supported in context-specific
      RUNX3 target-gene programs.
    action: ACCEPT
    reason: RUNX3 can activate transcriptional targets, although the direction of regulation is
      context dependent.
    supported_by: &id008
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
        primary function is as a **sequence-specific DNA-binding transcription factor** that
        regulates gene expression programs by binding target regulatory elements via the **Runt
        domain**, typically stabilized by heterodimerization with **CBFβ**.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: A 2024 study (Cancer Research Communications) presented evidence that RUNX3
        can be **pro-metastatic** in a gastric cancer model (HGC-27), where CRISPR KO reduced
        migration/invasion/anchorage-independent growth and suppressed liver metastasis in vivo.
        Multi-omic mapping (ChIP-seq, HiChIP) supported direct transcriptional control of
        metastasis-associated targets including **WNT5A**, **CD44**, and **VIM**, with WNT5A
        functioning as a major effector.
- term:
    id: GO:1990837
    label: sequence-specific double-stranded DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain
      sequence-specific DNA binding.
    action: ACCEPT
    reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
      function.
    supported_by: *id003
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18772112
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: &id004
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
        defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
        CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
        modulates transcriptional activity.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: 'A key 2023 advance demonstrated a **direct protein–protein mechanism** linking
        RUNX3 to oncogene control: RUNX3 binds **MYC** directly via the **Runt domain**, disrupts MYC’s
        transcriptionally active complexes (MYC–MAX and MYC–MIZ1), increases **GSK3β-mediated phosphorylation
        of MYC at T58**, and promotes **FBXW7-dependent K48-linked ubiquitination** and proteasomal degradation
        of MYC.'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:24229708
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: *id004
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: *id004
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:38424632
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: *id004
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9751710
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: *id004
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: cytosol localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0006357
    label: regulation of transcription by RNA polymerase II
  evidence_type: IDA
  original_reference_id: PMID:20591170
  review:
    summary: Regulation of transcription by RNA polymerase II is a core RUNX3 biological process.
    action: ACCEPT
    reason: RUNX3 regulates gene-expression programs as a nuclear sequence-specific transcription
      factor.
    supported_by: *id002
- term:
    id: GO:0001222
    label: transcription corepressor binding
  evidence_type: IPI
  original_reference_id: PMID:9751710
  review:
    summary: Transcription corepressor binding is supported by RUNX/Runt-domain recruitment of
      TLE/Groucho corepressors.
    action: ACCEPT
    reason: This is a more informative binding annotation than generic protein binding for
      RUNX3-associated transcriptional repression.
    supported_by:
    - reference_id: PMID:9751710
      supporting_text: The mammalian AML/CBFalpha runt domain (RD) transcription factors regulate
        hematopoiesis and osteoblast differentiation. Like their Drosophila counterparts, most
        mammalian RD proteins terminate in a common pentapeptide, VWRPY, which serves to recruit the
        corepressor Groucho (Gro).
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
        primary function is as a **sequence-specific DNA-binding transcription factor** that
        regulates gene expression programs by binding target regulatory elements via the **Runt
        domain**, typically stabilized by heterodimerization with **CBFβ**.
- term:
    id: GO:1990837
    label: sequence-specific double-stranded DNA binding
  evidence_type: IDA
  original_reference_id: PMID:28473536
  review:
    summary: sequence-specific double-stranded DNA binding is supported by RUNX3 Runt-domain
      sequence-specific DNA binding.
    action: ACCEPT
    reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
      function.
    supported_by: *id003
- term:
    id: GO:0000785
    label: chromatin
  evidence_type: ISA
  original_reference_id: GO_REF:0000113
  review:
    summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and
      chromatin-remodeler-associated activity.
    action: ACCEPT
    reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor
      function.
    supported_by: &id009
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin
        accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 associates with **CBFβ** and chromatin remodeler machinery including
        SWI/SNF components; the **Runt domain** is implicated as critical for interactions with
        chromatin factors in this metastatic gastric cancer model.
- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: ISA
  original_reference_id: GO_REF:0000113
  review:
    summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the
      best-supported core molecular function of RUNX3.
    action: ACCEPT
    reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA
      polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
    supported_by: *id002
- term:
    id: GO:0016513
    label: core-binding factor complex
  evidence_type: TAS
  original_reference_id: PMID:18258917
  review:
    summary: Core-binding factor complex is the canonical RUNX3 transcription factor complex
      context.
    action: ACCEPT
    reason: RUNX3 heterodimerizes with CBFβ, placing it in the core-binding factor complex for
      DNA-binding transcriptional regulation.
    supported_by:
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
        defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
        CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
        modulates transcriptional activity.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 associates with **CBFβ** and chromatin remodeler machinery including
        SWI/SNF components; the **Runt domain** is implicated as critical for interactions with
        chromatin factors in this metastatic gastric cancer model.
- term:
    id: GO:0043371
    label: negative regulation of CD4-positive, alpha-beta T cell differentiation
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: negative regulation of CD4-positive, alpha-beta T cell differentiation is a supported
      RUNX3 biological role, especially in immune differentiation, but it is downstream of the
      transcription factor core function.
    action: KEEP_AS_NON_CORE
    reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs
      rather than a separate core molecular activity.
    supported_by: &id007
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 is a key regulator of **CD8+ T-cell differentiation, infiltration,
        effector/memory fate, and residency**.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: '**RUNX3 is a master developmental transcription factor** whose dysregulation can
        impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).'
- term:
    id: GO:0043378
    label: positive regulation of CD8-positive, alpha-beta T cell differentiation
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: positive regulation of CD8-positive, alpha-beta T cell differentiation is a supported
      RUNX3 biological role, especially in immune differentiation, but it is downstream of the
      transcription factor core function.
    action: KEEP_AS_NON_CORE
    reason: T-cell differentiation phenotypes reflect RUNX3-regulated transcriptional programs
      rather than a separate core molecular activity.
    supported_by: *id007
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952419
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952399
  review:
    summary: cytosol localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952408
  review:
    summary: cytosol localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952382
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952399
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8951966
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8951977
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952058
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952062
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952069
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8937792
  review:
    summary: cytosol localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8937807
  review:
    summary: cytosol localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8937814
  review:
    summary: cytosol localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8865454
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8878117
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8878143
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8878178
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8878193
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8878220
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8878237
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8937814
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8949335
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8951428
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8951676
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8951910
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8951951
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952128
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952226
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8952371
  review:
    summary: nucleoplasm localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20599712
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: *id004
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:20599712
  review:
    summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:20599712
  review:
    summary: cytoplasm localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0045893
    label: positive regulation of DNA-templated transcription
  evidence_type: IDA
  original_reference_id: PMID:20599712
  review:
    summary: Positive regulation of DNA-templated transcription is supported in context-specific
      RUNX3 target-gene programs.
    action: ACCEPT
    reason: RUNX3 can activate transcriptional targets, although the direction of regulation is
      context dependent.
    supported_by: *id008
- term:
    id: GO:0071559
    label: response to transforming growth factor beta
  evidence_type: IDA
  original_reference_id: PMID:20599712
  review:
    summary: Response to transforming growth factor beta is supported as a pathway context for RUNX3
      transcriptional regulation.
    action: KEEP_AS_NON_CORE
    reason: TGF-beta/SMAD effects are important context-specific biology, but the core function
      remains nuclear sequence-specific transcriptional regulation.
    supported_by:
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: A 2024 review of RUNX transcription factors synthesizes RUNX3 as a regulator
        embedded in major cancer-relevant pathways, including **TGF-β/SMAD**, **Wnt/β-catenin**, and
        **Hippo–YAP** crosstalk, and emphasizes frequent RUNX3 inactivation through **promoter
        hypermethylation, histone modifications, and mislocalization**.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: '**RUNX3 is a master developmental transcription factor** whose dysregulation can
        impact multiple hallmark pathways (TGF-β, Wnt/β-catenin, Hippo-YAP, Notch/MAPK, etc.).'
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:17377532
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: *id004
- term:
    id: GO:0000785
    label: chromatin
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: Chromatin localization is supported by RUNX3 DNA, mononucleosome, and
      chromatin-remodeler-associated activity.
    action: ACCEPT
    reason: RUNX3 binds chromatin-associated regulatory DNA as part of its transcription factor
      function.
    supported_by: *id009
- term:
    id: GO:0000977
    label: RNA polymerase II transcription regulatory region sequence-specific DNA binding
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: RNA polymerase II transcription regulatory region sequence-specific DNA binding is
      supported by RUNX3 Runt-domain sequence-specific DNA binding.
    action: ACCEPT
    reason: Sequence-specific regulatory-region DNA binding is central to RUNX3 transcription factor
      function.
    supported_by: *id003
- term:
    id: GO:0000122
    label: negative regulation of transcription by RNA polymerase II
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: Negative regulation of transcription by RNA polymerase II is supported for RUNX3 in
      repressive target-gene and Wnt/TCF contexts.
    action: ACCEPT
    reason: RUNX3 can repress transcriptional outputs through protein complexes and target-gene
      regulation.
    supported_by:
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
        primary function is as a **sequence-specific DNA-binding transcription factor** that
        regulates gene expression programs by binding target regulatory elements via the **Runt
        domain**, typically stabilized by heterodimerization with **CBFβ**.
    - reference_id: PMID:18772112
      supporting_text: Here we found that RUNX3, a gastric tumor suppressor, forms a ternary complex
        with beta-catenin/TCF4 and attenuates Wnt signaling activity.
- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: DNA-binding transcription factor activity, RNA polymerase II-specific is the
      best-supported core molecular function of RUNX3.
    action: ACCEPT
    reason: RUNX3 is a sequence-specific Runt-domain transcription factor that regulates RNA
      polymerase II transcription through DNA/chromatin binding and CBFβ-associated complexes.
    supported_by: *id002
- term:
    id: GO:0048935
    label: peripheral nervous system neuron development
  evidence_type: TAS
  original_reference_id: PMID:20096094
  review:
    summary: peripheral nervous system neuron development is consistent with RUNX3 developmental or
      disease-associated transcriptional programs but is not the core molecular function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: *id001
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:20100835
  review:
    summary: nucleus localization is central to RUNX3 canonical transcription factor activity.
    action: ACCEPT
    reason: RUNX3 acts in the nucleus/nucleoplasm to bind chromatin and regulate transcription.
    supported_by: *id005
- term:
    id: GO:0006468
    label: protein phosphorylation
  evidence_type: IDA
  original_reference_id: PMID:20100835
  review:
    summary: Protein phosphorylation is not supported as a process carried out by RUNX3.
    action: REMOVE
    reason: The cited biology describes Src-mediated phosphorylation of RUNX3, making RUNX3 the
      substrate rather than the kinase or causal gene product for protein phosphorylation.
    supported_by:
    - reference_id: PMID:20100835
      supporting_text: In this study, we found that the overexpression of Src results in the
        tyrosine phosphorylation and cytoplasmic localization of RUNX3.
    - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
      supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
        and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
        can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides
        a mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export
        machinery.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20100835
  review:
    summary: Protein binding is supported in many RUNX3 contexts but is too generic to describe the
      main function.
    action: MARK_AS_OVER_ANNOTATED
    reason: RUNX3 has specific partner interactions such as CBFβ, MYC, TLE/corepressors, SMADs, and
      chromatin factors, but the unqualified protein binding term is not informative for curation.
    supported_by: *id004
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:20100835
  review:
    summary: cytoplasm localization is supported, but mainly as a mislocalization/export or
      degradation context rather than the canonical site of RUNX3 function.
    action: KEEP_AS_NON_CORE
    reason: RUNX3 core activity is nuclear transcriptional regulation; cytoplasmic/cytosolic
      localization is best treated as a regulated non-core or inactivation-associated state.
    supported_by: *id006
- term:
    id: GO:0045786
    label: negative regulation of cell cycle
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: negative regulation of cell cycle is consistent with RUNX3 developmental or
      disease-associated transcriptional programs but is not the core molecular function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: *id001
- term:
    id: GO:0050680
    label: negative regulation of epithelial cell proliferation
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: negative regulation of epithelial cell proliferation is consistent with RUNX3
      developmental or disease-associated transcriptional programs but is not the core molecular
      function.
    action: KEEP_AS_NON_CORE
    reason: These developmental, cell-cycle, or tissue-level outcomes are downstream consequences of
      RUNX3 transcription factor activity and should not be treated as the core function itself.
    supported_by: *id001
- term:
    id: GO:0003700
    label: DNA-binding transcription factor activity
  evidence_type: TAS
  original_reference_id: PMID:7607690
  review:
    summary: Generic DNA-binding transcription factor activity is correct but less precise than the
      RNA polymerase II-specific term already present.
    action: MODIFY
    reason: RUNX3 functions as a sequence-specific RNA polymerase II transcription factor, so the
      more specific term is preferred.
    proposed_replacement_terms: *id010
    supported_by: *id002
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: NAS
  original_reference_id: PMID:7835892
  review:
    summary: ATP binding is not supported as a RUNX3 molecular function.
    action: REMOVE
    reason: RUNX3 is a non-enzymatic DNA-binding transcription factor; ATP-dependent
      chromatin-remodeling context should not be transferred to RUNX3 as ATP binding.
    supported_by: *id011
- term:
    id: GO:0006355
    label: regulation of DNA-templated transcription
  evidence_type: NAS
  original_reference_id: PMID:7622058
  review:
    summary: Generic regulation of DNA-templated transcription is supported but should be captured
      with the RNA polymerase II-specific process.
    action: MODIFY
    reason: RUNX3 target-gene regulation is best represented by regulation of transcription by RNA
      polymerase II.
    proposed_replacement_terms: *id012
    supported_by: *id002
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by
    curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary
    mapping, accompanied by conservative changes to GO terms applied by UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000113
  title: Gene Ontology annotation of human sequence-specific DNA binding transcription factors
    (DbTFs) based on the TFClass database
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:17377532
  title: Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
  findings: []
- id: PMID:18258917
  title: Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell
    development.
  findings: []
- id: PMID:18772112
  title: RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
  findings: []
- id: PMID:20096094
  title: Brn3a regulates neuronal subtype specification in the trigeminal ganglion by promoting Runx
    expression during sensory differentiation.
  findings: []
- id: PMID:20100835
  title: Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the
    cytoplasm.
  findings: []
- id: PMID:20591170
  title: The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer
    cells.
  findings: []
- id: PMID:20599712
  title: Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt
    domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
  findings: []
- id: PMID:24229708
  title: Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
  findings: []
- id: PMID:28473536
  title: Impact of cytosine methylation on DNA binding specificities of human transcription factors.
  findings: []
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
  findings: []
- id: PMID:38424632
  title: Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in
    lung adenocarcinoma.
  findings: []
- id: PMID:7607690
  title: Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the
    human homolog, CBFA3, to chromosome 1p35-pter.
  findings: []
- id: PMID:7622058
  title: Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt
    domain.
  findings: []
- id: PMID:7835892
  title: 'AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression,
    and chromosomal localization.'
  findings: []
- id: PMID:9751710
  title: Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.
  findings: []
- id: Reactome:R-HSA-8865454
  title: CBFB binds RUNX3
  findings: []
- id: Reactome:R-HSA-8878117
  title: RUNX3 binds ZFHX3
  findings: []
- id: Reactome:R-HSA-8878143
  title: RUNX3 binds SMAD3 and SMAD4
  findings: []
- id: Reactome:R-HSA-8878178
  title: The complex of RUNX3, SMAD3 and SMAD4 binds the CDKN1A gene promoter
  findings: []
- id: Reactome:R-HSA-8878193
  title: RUNX3 binds the JAG1 gene promoter
  findings: []
- id: Reactome:R-HSA-8878220
  title: RUNX3 binds the NOTCH1 coactivator complex
  findings: []
- id: Reactome:R-HSA-8878237
  title: RUNX3:NOTCH1 coactivator complex binds the HES1 gene promoter
  findings: []
- id: Reactome:R-HSA-8937792
  title: RUNX3 binds SRC
  findings: []
- id: Reactome:R-HSA-8937807
  title: SRC phosphorylates RUNX3
  findings: []
- id: Reactome:R-HSA-8937814
  title: RUNX3 translocates to the nucleus
  findings: []
- id: Reactome:R-HSA-8949335
  title: RUNX3:CBFB binds the ITGAL gene,(ITGA4 gene) promoter
  findings: []
- id: Reactome:R-HSA-8951428
  title: RUNX3 binds CTNNB1:TCF7L2,(LEF1,TCF7L1,TCF7)
  findings: []
- id: Reactome:R-HSA-8951676
  title: RUNX3 binds TEADs and YAP1
  findings: []
- id: Reactome:R-HSA-8951910
  title: RUNX3 binds the RUNX1 promoter
  findings: []
- id: Reactome:R-HSA-8951951
  title: RUNX3 binds EP300
  findings: []
- id: Reactome:R-HSA-8951966
  title: EP300 acetylates RUNX3
  findings: []
- id: Reactome:R-HSA-8951977
  title: Acetylated RUNX3 binds to BRD2
  findings: []
- id: Reactome:R-HSA-8952058
  title: CCND1 binds RUNX3 and displaces EP300
  findings: []
- id: Reactome:R-HSA-8952062
  title: CCND1 recruits HDAC4 to RUNX3
  findings: []
- id: Reactome:R-HSA-8952069
  title: HDAC4 deacetylates RUNX3
  findings: []
- id: Reactome:R-HSA-8952128
  title: RUNX3 binds TP53
  findings: []
- id: Reactome:R-HSA-8952226
  title: RUNX3 binds the BCL2L11 (BIM) gene
  findings: []
- id: Reactome:R-HSA-8952371
  title: MDM2 binds RUNX3
  findings: []
- id: Reactome:R-HSA-8952382
  title: MDM2 polyubiquitinates RUNX3
  findings: []
- id: Reactome:R-HSA-8952399
  title: Polyubiquitinated RUNX3 translocates to the cytosol
  findings: []
- id: Reactome:R-HSA-8952408
  title: Polyubiquitinated RUNX3 is degraded by the proteasome
  findings: []
- id: Reactome:R-HSA-8952419
  title: SMURFs ubiquitinate RUNX3
  findings: []
- id: file:human/RUNX3/RUNX3-deep-research-falcon.md
  title: Falcon deep research synthesis for RUNX3
  findings: []
core_functions:
- description: Nuclear Runt-domain sequence-specific transcription factor activity in
    CBFβ/core-binding factor complexes, regulating RNA polymerase II target-gene programs through
    chromatin and regulatory-region DNA binding.
  molecular_function:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  directly_involved_in:
  - id: GO:0006357
    label: regulation of transcription by RNA polymerase II
  - id: GO:0045893
    label: positive regulation of DNA-templated transcription
  - id: GO:0000122
    label: negative regulation of transcription by RNA polymerase II
  locations:
  - id: GO:0005634
    label: nucleus
  - id: GO:0005654
    label: nucleoplasm
  - id: GO:0000785
    label: chromatin
  in_complex:
    id: GO:0016513
    label: core-binding factor complex
  supported_by:
  - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
    supporting_text: RUNX3 is **not an enzyme** and does not catalyze a chemical reaction; its
      primary function is as a **sequence-specific DNA-binding transcription factor** that regulates
      gene expression programs by binding target regulatory elements via the **Runt domain**,
      typically stabilized by heterodimerization with **CBFβ**.
  - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
    supporting_text: RUNX family proteins (RUNX1/2/3) are sequence-specific transcription factors
      defined by a conserved **Runt DNA-binding domain**; they functionally **heterodimerize with
      CBFβ**, a non–DNA-binding partner that stabilizes RUNX binding to target DNA elements and
      modulates transcriptional activity.
  - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
    supporting_text: RUNX3 can bind DNA and **mononucleosomes**, and RUNX3 loss alters chromatin
      accessibility and transcriptional programs (ATAC-seq/RNA-seq integration).
  - reference_id: file:human/RUNX3/RUNX3-deep-research-falcon.md
    supporting_text: RUNX3’s canonical site of action is the **nucleus**, where it binds chromatin
      and regulates transcription. Multiple studies emphasize that **cytoplasmic mislocalization**
      can functionally inactivate RUNX3 by preventing nuclear activity; oxidative stress provides a
      mechanistic route for nuclear export via Src phosphorylation and JAB1/CRM1 export machinery.
proposed_new_terms: []
suggested_questions: []
suggested_experiments: []